Linney Yvonne 4
4 · Bionano Genomics, Inc. · Filed Aug 17, 2022
Insider Transaction Report
Form 4
Linney Yvonne
Director
Transactions
- Sale
Common Stock
2022-08-15$3.62/sh−20,000$72,402→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-08-15−20,000→ 60,923 totalExercise: $0.38Exp: 2030-05-04→ Common Stock (20,000 underlying) - Exercise/Conversion
Common Stock
2022-08-15$0.38/sh+20,000$7,600→ 20,000 total
Footnotes (1)
- [F1]The shares vest in equal monthly installments over a three year period such that the option is fully vested on May 4, 2023, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan).